ArticleScientific reports2025
Red blood cell distribution width and mortality in chronic obstructive pulmonary disease patients with acute respiratory failure: a retrospective study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal machine learning predicts type 2 respiratory failure in COPD exacerbations: a multicenter XGBoost model with clinical nomogram.Frontiers in medicine · 2026Article
- Red Cell Distribution Width Predicts Mortality in Critically Ill Patients with COPD and Atrial Fibrillation: A Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To assess the association between red blood cell distribution width (RDW) levels and mortality in chronic obstructive pulmonary disease (COPD) patients with acute respiratory failure (ARF). We included patients with COPD admitted to the intensive care unit (ICU) across 208 U.S. hospitals between 2014 and 2015. The primary outcomes were ICU and in-hospital mortality. We employed univariable and multivariable logistic regression models to assess the association between RDW and mortality outcomes in COPD patients with ARF. To evaluate potential non-linear relationships, we utilized a generalized additive model (GAM) with smooth curve fitting. Additionally, a two-piecewise linear regression model was applied to identify the inflection point of RDW in relation to mortality risk. Sensitivity analyses were conducted to validate the robustness and reliability of the findings. This study included a total of 3,489 patients, with a mean age of 68.01 ± 11.29 years, of whom 1,669 (47.92%) were male. The RDW ranged from 11.40 to 29.20%, with a median value of 15.10%. The ICU mortality rate was 9.2%, while the in-hospital mortality rate was 15.28%. After adjusting for confounding factors, RDW was positively associated with the risk of ICU mortality in COPD patients with ARF (OR 1.08, 95% CI 1.03-1.14), and it was also positively associated with the risk of in-hospital mortality (OR 1.08, 95% CI 1.04-1.13). Furthermore, we observed a nonlinear relationship between RDW and ICU mortality risk, with a threshold effect. However, we did not find a nonlinear relationship between RDW and in-hospital mortality. Sensitivity and subgroup analyses confirmed the robustness of the relationship between RDW and mortality in COPD patients with ARF. RDW is positively correlated with both ICU mortality and in-hospital mortality in COPD patients with ARF. A nonlinear association was noted between RDW and ICU mortality, whereas a linear association was observed with in-hospital mortality. Further research is needed to investigate the mechanisms underlying these associations and to assess RDW's potential as a prognostic marker for critically ill COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.